Johnson & Johnson Tops the Tape

Johnson & Johnson stock is jumping over 6% on better than expected earnings. Stronger sales in the company's MedTech business boosting the balance sheet as demand for non-urgent surgeries rebounded during the quarter. Karen: One of the things we know is that when you have a mature growth company, you don't generate a lot of alpha.